DK0500791T3 - Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA - Google Patents
Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNAInfo
- Publication number
- DK0500791T3 DK0500791T3 DK91900636.1T DK91900636T DK0500791T3 DK 0500791 T3 DK0500791 T3 DK 0500791T3 DK 91900636 T DK91900636 T DK 91900636T DK 0500791 T3 DK0500791 T3 DK 0500791T3
- Authority
- DK
- Denmark
- Prior art keywords
- cys
- retroviruses
- infectivity
- array
- amino acids
- Prior art date
Links
- 208000015181 infectious disease Diseases 0.000 title abstract 2
- 230000002458 infectious effect Effects 0.000 title abstract 2
- 238000010276 construction Methods 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 4
- 241000725303 Human immunodeficiency virus Species 0.000 abstract 2
- 108020000999 Viral RNA Proteins 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 108010076039 Polyproteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 230000000973 chemotherapeutic effect Effects 0.000 abstract 1
- 230000000295 complement effect Effects 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000017613 viral reproduction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42928789A | 1989-10-31 | 1989-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0500791T3 true DK0500791T3 (da) | 1998-04-06 |
Family
ID=23702610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91900636.1T DK0500791T3 (da) | 1989-10-31 | 1990-10-31 | Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0500791B1 (da) |
| JP (1) | JPH0716420B2 (da) |
| AT (1) | ATE162949T1 (da) |
| AU (1) | AU636755B2 (da) |
| CA (1) | CA2072125C (da) |
| DE (1) | DE69032028T2 (da) |
| DK (1) | DK0500791T3 (da) |
| ES (1) | ES2111559T3 (da) |
| GR (1) | GR3026457T3 (da) |
| WO (1) | WO1991006318A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861282A (en) * | 1989-10-16 | 1999-01-19 | Whitehead Institute For Biomedical Research | Non-infectious HIV particles and uses therefor |
| US5532154A (en) * | 1994-03-21 | 1996-07-02 | Research Development Foundation | Mutated alpha virus |
| US6316190B1 (en) | 1996-05-20 | 2001-11-13 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Oligonucleotides which specifically bind retroviral nucleocapsid proteins |
| CA2418091A1 (en) * | 2000-08-08 | 2002-02-14 | The Kitasato Institute | Virus-like particles and process for producing the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2067778A1 (en) * | 1989-10-16 | 1991-04-17 | The Whitehead Institute For Biomedical Research | Non-infectious hiv-1 particles and uses therefor |
-
1990
- 1990-10-31 DK DK91900636.1T patent/DK0500791T3/da active
- 1990-10-31 EP EP91900636A patent/EP0500791B1/en not_active Expired - Lifetime
- 1990-10-31 AT AT91900636T patent/ATE162949T1/de not_active IP Right Cessation
- 1990-10-31 AU AU77402/91A patent/AU636755B2/en not_active Ceased
- 1990-10-31 ES ES91900636T patent/ES2111559T3/es not_active Expired - Lifetime
- 1990-10-31 WO PCT/US1990/006231 patent/WO1991006318A1/en active IP Right Grant
- 1990-10-31 JP JP3500783A patent/JPH0716420B2/ja not_active Expired - Fee Related
- 1990-10-31 DE DE69032028T patent/DE69032028T2/de not_active Expired - Fee Related
- 1990-10-31 CA CA002072125A patent/CA2072125C/en not_active Expired - Fee Related
-
1998
- 1998-03-27 GR GR980400641T patent/GR3026457T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69032028D1 (de) | 1998-03-12 |
| DE69032028T2 (de) | 1998-05-20 |
| WO1991006318A1 (en) | 1991-05-16 |
| AU636755B2 (en) | 1993-05-06 |
| EP0500791B1 (en) | 1998-02-04 |
| GR3026457T3 (en) | 1998-06-30 |
| CA2072125C (en) | 2000-05-23 |
| EP0500791A4 (en) | 1993-02-10 |
| EP0500791A1 (en) | 1992-09-02 |
| ATE162949T1 (de) | 1998-02-15 |
| AU7740291A (en) | 1991-05-31 |
| JPH0716420B2 (ja) | 1995-03-01 |
| JPH04505163A (ja) | 1992-09-10 |
| CA2072125A1 (en) | 1991-05-01 |
| ES2111559T3 (es) | 1998-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Simon et al. | The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes | |
| Leis et al. | Standardized and simplified nomenclature for proteins common to all retroviruses | |
| Peters et al. | Resistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein | |
| ATE315667T1 (de) | Amplifizierung und detektion von hiv-1 und/oder hiv-2 | |
| WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
| KR920703639A (ko) | 항-바이러스제와 이뮤노겐으로 유용하게 사용되는 비-복제성 리콤비넌트 레트로바이러스 물질 | |
| Sala et al. | Are RNA viruses adapting or merely changing? | |
| Mselli-Lakhal et al. | Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells | |
| DE69836395D1 (de) | Primern zum Nachweis von HIV-1 | |
| DK0500791T3 (da) | Udformning og konstruktion af ikke-infektiøse human retrovirale mutanter, der mangler genomisk DNA | |
| KR890701738A (ko) | 인체면역결핍 비루스 특이성 단백질분해효소와 이들의 합성 및 원형재현 방법 | |
| AU7028998A (en) | Retroviral vectors, method for the production and the use thereof for gene transfer in cd4-positive cells | |
| DK172633B1 (da) | Fremgangsmåde til fremstilling af en FeLV-vaccine og sammensætning og vaccine omfattende en således fremstillet inaktiveret | |
| DK631387A (da) | Virusvektor | |
| LAMERS et al. | A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses | |
| Meyerhans et al. | The non-clonal and transitory nature of HIV in vivo | |
| Gray et al. | Nucleotide sequence of the core (gag) gene from HTLV-1 isolate MT-2. | |
| Inubushi et al. | Cell-dependent function of HIV-1 Vif for virus replication | |
| Wrobel et al. | Analysis of HIV type 1 reverse transcriptase: comparing sequences of viral isolates with mutational data | |
| Wain-Hobson | Retroviral G 3 A hypermutation | |
| ATE417108T1 (de) | Hiv-2 und siv-1 nukleotidsequenzen | |
| DE3877212D1 (de) | Antivirale anwendung von alpha-oligonucleotiden. | |
| Clementi | HIV and Molecular Biology of the Virus‐Host Interplay |